A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma
Shiwei Guo, Jing Shen, Junhui Gao, Xiaohan Shi, Suizhi Gao, Huan Wang, Bo Li, Weilan Yuan, Ling Lin, Gang Jin
Topics & Concepts
MedicineCarcinoembryonic antigenNeoadjuvant therapyNomogramChemotherapyProportional hazards modelStage (stratigraphy)Multivariate analysisAdenocarcinomaUnivariate analysisOncologyPancreatectomySurgeryInternal medicineRadiologyCancerPancreasBreast cancerBiologyPaleontologyPancreatic and Hepatic Oncology ResearchEsophageal Cancer Research and TreatmentCholangiocarcinoma and Gallbladder Cancer Studies